A putrescine-anthracene conjugate: a paradigm for selective drug delivery

Andrew J Palmer, Radiah A Ghani, Navneet Kaur, Otto Phanstiel, Heather M Wallace

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Increased polyamine concentrations play an important role in the development of cancer at all stages, from initiation through to maintenance of the transformed phenotype. One way cancer cells accumulate increased concentrations of polyamines is by increased uptake of preformed polyamines via their PTS (polyamine transport system). The PTS is promiscuous and will transport a range of polyamine-based molecules. Therefore it may be that cytotoxic drugs could be attached to polyamine vectors and targeted selectively to cancer cells by utilizing the PTS. The aim of the present study was to investigate the potential of Ant 4, a putrescine–anthracene conjugate, to target cytotoxic agents to human cancer cells as a paradigm for a novel method of selective drug delivery. Ant 4 induced cytotoxicity after only 24 h exposure. Apoptosis was the predominant type of cell death, with mechanistic studies revealing that oxidative stress and DNA damage may have a part to play. For the first time, uptake of Ant 4 via the PTS was demonstrated both directly and indirectly in human cell lines. In addition, Ant 4 significantly reduced putrescine uptake, demonstrating that this conjugate not only used the PTS, but also could successfully compete with its native polyamine for uptake. However, the most interesting finding was the intracellular depletion of the polyamine pools, providing an additional mode of toxicity for Ant 4 and the possibility that this molecule may act as a ‘double-edged sword’: preventing cell growth by delivery of the toxic moiety and by depletion of intracellular polyamine content.
Original languageEnglish
Pages (from-to)431-438
Number of pages8
JournalBiochemical Journal
Volume424
Issue number3
Early online date8 Oct 2009
DOIs
Publication statusPublished - 15 Dec 2009

Fingerprint

Putrescine
Polyamines
Drug delivery
Pharmaceutical Preparations
Ants
Cells
anthracene
Neoplasms
Molecules
Oxidative stress
Poisons
Cytotoxins
Cell growth
Cell death
Cytotoxicity
DNA Damage
Toxicity
Oxidative Stress
Cell Death

Keywords

  • anticancer drug
  • polyamine
  • transporter
  • apoptosis
  • cancer
  • DNA damage
  • drug conjugate
  • leukemia

Cite this

A putrescine-anthracene conjugate : a paradigm for selective drug delivery. / Palmer, Andrew J; Ghani, Radiah A; Kaur, Navneet; Phanstiel, Otto; Wallace, Heather M.

In: Biochemical Journal, Vol. 424, No. 3, 15.12.2009, p. 431-438.

Research output: Contribution to journalArticle

Palmer, Andrew J ; Ghani, Radiah A ; Kaur, Navneet ; Phanstiel, Otto ; Wallace, Heather M. / A putrescine-anthracene conjugate : a paradigm for selective drug delivery. In: Biochemical Journal. 2009 ; Vol. 424, No. 3. pp. 431-438.
@article{5e74def4da16452d9d763e2ddd3b4f28,
title = "A putrescine-anthracene conjugate: a paradigm for selective drug delivery",
abstract = "Increased polyamine concentrations play an important role in the development of cancer at all stages, from initiation through to maintenance of the transformed phenotype. One way cancer cells accumulate increased concentrations of polyamines is by increased uptake of preformed polyamines via their PTS (polyamine transport system). The PTS is promiscuous and will transport a range of polyamine-based molecules. Therefore it may be that cytotoxic drugs could be attached to polyamine vectors and targeted selectively to cancer cells by utilizing the PTS. The aim of the present study was to investigate the potential of Ant 4, a putrescine–anthracene conjugate, to target cytotoxic agents to human cancer cells as a paradigm for a novel method of selective drug delivery. Ant 4 induced cytotoxicity after only 24 h exposure. Apoptosis was the predominant type of cell death, with mechanistic studies revealing that oxidative stress and DNA damage may have a part to play. For the first time, uptake of Ant 4 via the PTS was demonstrated both directly and indirectly in human cell lines. In addition, Ant 4 significantly reduced putrescine uptake, demonstrating that this conjugate not only used the PTS, but also could successfully compete with its native polyamine for uptake. However, the most interesting finding was the intracellular depletion of the polyamine pools, providing an additional mode of toxicity for Ant 4 and the possibility that this molecule may act as a ‘double-edged sword’: preventing cell growth by delivery of the toxic moiety and by depletion of intracellular polyamine content.",
keywords = "anticancer drug, polyamine, transporter, apoptosis, cancer, DNA damage, drug conjugate, leukemia",
author = "Palmer, {Andrew J} and Ghani, {Radiah A} and Navneet Kaur and Otto Phanstiel and Wallace, {Heather M}",
year = "2009",
month = "12",
day = "15",
doi = "10.1042/BJ20090815",
language = "English",
volume = "424",
pages = "431--438",
journal = "Biochemical Journal",
issn = "0264-6021",
publisher = "Portland Press Ltd.",
number = "3",

}

TY - JOUR

T1 - A putrescine-anthracene conjugate

T2 - a paradigm for selective drug delivery

AU - Palmer, Andrew J

AU - Ghani, Radiah A

AU - Kaur, Navneet

AU - Phanstiel, Otto

AU - Wallace, Heather M

PY - 2009/12/15

Y1 - 2009/12/15

N2 - Increased polyamine concentrations play an important role in the development of cancer at all stages, from initiation through to maintenance of the transformed phenotype. One way cancer cells accumulate increased concentrations of polyamines is by increased uptake of preformed polyamines via their PTS (polyamine transport system). The PTS is promiscuous and will transport a range of polyamine-based molecules. Therefore it may be that cytotoxic drugs could be attached to polyamine vectors and targeted selectively to cancer cells by utilizing the PTS. The aim of the present study was to investigate the potential of Ant 4, a putrescine–anthracene conjugate, to target cytotoxic agents to human cancer cells as a paradigm for a novel method of selective drug delivery. Ant 4 induced cytotoxicity after only 24 h exposure. Apoptosis was the predominant type of cell death, with mechanistic studies revealing that oxidative stress and DNA damage may have a part to play. For the first time, uptake of Ant 4 via the PTS was demonstrated both directly and indirectly in human cell lines. In addition, Ant 4 significantly reduced putrescine uptake, demonstrating that this conjugate not only used the PTS, but also could successfully compete with its native polyamine for uptake. However, the most interesting finding was the intracellular depletion of the polyamine pools, providing an additional mode of toxicity for Ant 4 and the possibility that this molecule may act as a ‘double-edged sword’: preventing cell growth by delivery of the toxic moiety and by depletion of intracellular polyamine content.

AB - Increased polyamine concentrations play an important role in the development of cancer at all stages, from initiation through to maintenance of the transformed phenotype. One way cancer cells accumulate increased concentrations of polyamines is by increased uptake of preformed polyamines via their PTS (polyamine transport system). The PTS is promiscuous and will transport a range of polyamine-based molecules. Therefore it may be that cytotoxic drugs could be attached to polyamine vectors and targeted selectively to cancer cells by utilizing the PTS. The aim of the present study was to investigate the potential of Ant 4, a putrescine–anthracene conjugate, to target cytotoxic agents to human cancer cells as a paradigm for a novel method of selective drug delivery. Ant 4 induced cytotoxicity after only 24 h exposure. Apoptosis was the predominant type of cell death, with mechanistic studies revealing that oxidative stress and DNA damage may have a part to play. For the first time, uptake of Ant 4 via the PTS was demonstrated both directly and indirectly in human cell lines. In addition, Ant 4 significantly reduced putrescine uptake, demonstrating that this conjugate not only used the PTS, but also could successfully compete with its native polyamine for uptake. However, the most interesting finding was the intracellular depletion of the polyamine pools, providing an additional mode of toxicity for Ant 4 and the possibility that this molecule may act as a ‘double-edged sword’: preventing cell growth by delivery of the toxic moiety and by depletion of intracellular polyamine content.

KW - anticancer drug

KW - polyamine

KW - transporter

KW - apoptosis

KW - cancer

KW - DNA damage

KW - drug conjugate

KW - leukemia

U2 - 10.1042/BJ20090815

DO - 10.1042/BJ20090815

M3 - Article

VL - 424

SP - 431

EP - 438

JO - Biochemical Journal

JF - Biochemical Journal

SN - 0264-6021

IS - 3

ER -